One Johnson and Johnson Plaza in New Brunswick, New Jersey... 6 Illegal marketing of Risperdal 6.7 Foreign bribery 6.8... 1 Northeastern Ohio Settlement 7 Public-private engagement 7.1...
29 Johnson & Johnson: Off-label promotion of Risperdal, Invega and Natrecor, November 2013 1.... the settlement was announced after eight years of litigation in May 2004. Warner-Lambert...
Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and... 2 Centocor products 4 Risperdal deception 5 See also 6 References 6.1 Bibliography 7 External links...
Act) settlement and criminal fine. Glaxo's $3 billion settlement... Johnson & Johnson [7] $2.2 billion Off-label promotion, kickbacks Risperdal , Invega , Nesiritide False Claims Act, FDCA...
Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription d...
The drug industry, and “sales over science.” Muckracker journalist Steven Brill goes after Johnson & Johnson and more. He’s with us.
Johnson & Johnson and a subsidiary were ordered to pay $8 billion in punitive damages after lawyers argued anitpsychotic drug Risperdal was linked to abnormal growth of female breast tissue in boys.
Johnson & Johnson will pay $2.2 billion to settle civil and criminal investigations related to mis-marketing of prescription drugs Risperdal, Invega and Natrecor.
States, the federal government and thousands of individuals have filed lawsuits over the drug Risperdal, costing the drugmaker Johnson & Johnson billions.
Johnson announced Thursday that its pharmaceutical unit had reached a $181 million consumer fraud settlement with 36 states and the District of Columbia over its marketing of Risperdal, an...